What is NDC 68180-288?

68180-288 is the product NDC for Abacavir and Lamivudine, Abacavir sulfate 600 mg/1; Lamivudine 300 mg/1 tablet, film coated, listed with the FDA by Lupin Pharmaceuticals, Inc..

Lupin Pharmaceuticals, Inc., NDC labeler code 68180. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Abacavir and Lamivudine?

5 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Abacavir and Lamivudine NDC 68180-288

NDC codes

FDA NDC Directory

Product NDC (as listed)68180-288Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68180-0288Add the package segment from the table below.

Product information

Brand name (proprietary): Abacavir and Lamivudine
Generic name (nonproprietary): abacavir and lamivudine
Active ingredients: Abacavir sulfate — 600 mg/1Lamivudine — 300 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Lupin Pharmaceuticals, Inc.NDC labeler code 68180
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204990
Marketing start: Mar 28, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 1A1 Inhibitors (Mechanism)Nucleoside Reverse Transcriptase Inhibitors (Mechanism)Nucleoside Reverse Transcriptase Inhibitors (Mechanism)
Identifiers: Product ID 68180-288_61b0304c-2258-40ed-9fc8-bc363b0906f6SPL ID 61b0304c-2258-40ed-9fc8-bc363b0906f6SPL set ID 1d8e7bb9-8624-4739-9719-fe25109d6365RxCUI 602393UNII J220T4J9Q2, 2T8Q726O95UPC 0368180288060
Pharmacologic class: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match: No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

Product label

Current FDA label (SPL), effective Oct 30, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

Abacavir and lamivudine tablet, a combination of abacavir and lamivudine, both nucleoside analogue HIV-1 reverse transcriptase inhibitors, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. ( 1 ) Abacavir and lamivudine tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68180-288

What is NDC 68180-288?: 68180-288 is the product NDC for Abacavir and Lamivudine, Abacavir sulfate 600 mg/1; Lamivudine 300 mg/1 tablet, film coated, listed with the FDA by Lupin Pharmaceuticals, Inc..
What drug is associated with this NDC?: Abacavir and Lamivudine.
What is the active ingredient?: Abacavir sulfate, Lamivudine.
Who is the labeler?: Lupin Pharmaceuticals, Inc., NDC labeler code 68180. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Abacavir and Lamivudine?: 5 other product NDCs are listed under this name. See all Abacavir and Lamivudine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Abacavir and Lamivudine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
ABACAVIR and LAMIVUDINE	Abacavir sulfate 600 mg/1; Lamivudine 300 mg/1	Tablet, Film coatedOral	Camber Pharmaceuticals, Inc.	31722-838	31722-0838-30
Abacavir and Lamivudine	Abacavir sulfate 600 mg/1; Lamivudine 300 mg/1	Tablet, Film coatedOral	Macleods Pharmaceuticals Limited	33342-440	33342-0440-0733342-0440-1433342-0440-98
Abacavir and Lamivudine	Abacavir sulfate 600 mg/1; Lamivudine 300 mg/1	Tablet, Film coatedOral	Laurus Labs Limited	42385-962	42385-0962-1842385-0962-3042385-0962-90
Abacavir and Lamivudine	Abacavir sulfate 600 mg/1; Lamivudine 300 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-335	65862-0335-1065862-0335-30
Abacavir and Lamivudine	Abacavir sulfate 600 mg/1; Lamivudine 300 mg/1	Tablet, Film coatedOral	Cipla USA Inc.	69097-362	69097-0362-02